IntroductionIn high-stakes pharmaceutical manufacturing, the chemical integrity of an active pharmaceutical ingredient (API) depends heavily on the purity, structural consistency, and physical stability of its starting intermediates. For targeted oncology drugs—particularly non-steroidal antiandroge
Read More